General Motors’ hot new SUV will be made in Mexico.
The rebooted Chevrolet Blazer is part of GM’s attempt to make SUVs in all shapes and sizes to quench Americans’ insatiable thirst for big cars. The Blazer is bigger than an Equinox but smaller than a Traverse.
GM hasn’t made a Blazer since 2005. The new Blazer doesn’t look like the old one, but like the original Blazer, it’s aimed at a younger audience.
Why is GM building such a high-profile SUV aimed at an American audience in its Ramos, Mexico, plant?
Mexican plants have cheaper labor costs than in the United States, and GM’s Ramos plant is already set up to manufacture bigger cars, including the Equinox SUV. (It also makes the smaller hatchback Cruze there.)
GM operates three assembly plants in Mexico. The Silao and San Luis Potosi locations are the two others. The company employs about 15,000 there.
But the decision to build autos in Mexico is fraught with controversy.
Hot Heal Care Stocks To Buy For 2019: Akorn, Inc.(AKRX)
Advisors’ Opinion:
- [By Chris Lange]
Akorn Inc. (NASDAQ: AKRX) saw its shares crater on Tuesday after some doubts were cast on its potential acquisition by German health care group Fresnius. This isnt the first time that Akorn has faced concerns regarding its security, but this could be the costliest.
- [By Joseph Griffin]
Akorn (NASDAQ:AKRX) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Monday.
- [By Chris Lange]
Akorn Inc. (NASDAQ: AKRX) shares were crushed on Monday (although not as bad as at Prothena)after it was announced that the German firm Fresenius would no longer be purchasing Akorn. Fresenius noted that this was the result of alleged breaches and data integrity requirements. However, Akorn intends to fight this, but who will win is still yet to be seen.
- [By Paul Ausick]
Akorn Inc. (NASDAQ: AKRX) dropped nearly 40% Tuesday to post a new 52-week low of $18.20. Shares closed at $30.28 on Monday and the stock’s 52-week high is $34.00. Volume was nearly 22 million, more than 20 times the daily average. A potential acquirer has announced an investigation into possible data breaches. 247wallst.com/healthcare-business/2018/02/27/could-data-breaches-break-up-the-akorn-aquisition/
- [By Ethan Ryder]
Akorn, Inc. (NASDAQ:AKRX) has received a consensus rating of “Hold” from the ten brokerages that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a strong buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $24.33.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers
Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent
Hot Heal Care Stocks To Buy For 2019: Piper Jaffray Companies(PJC)
Advisors’ Opinion:
- [By Joseph Griffin]
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
Get Piper Jaffray Companies alerts:
Financials still look pretty bleak after snapping their worst losing streak on record (cnbc.com) Buy Apple-supplier Lumentum because demand for its 3D sensors will surge: Piper (cnbc.com) Reviewing Piper Jaffray Companies (PJC) & Cowen Inc Class A (COWN) (americanbankingnews.com) Exclusive: These four San Francisco Bay Area stocks doubled in the first half of 2018, and here's why (finance.yahoo.com) Piper Jaffray and Kepler Cheuvreux Announce Extension of Equity Research Distribution Agreement to Switzerland (finance.yahoo.com)
NYSE:PJC traded down $1.05 during mid-day trading on Wednesday, hitting $76.40. The stock had a trading volume of 37,147 shares, compared to its average volume of 88,276. The company has a market cap of $1.18 billion, a PE ratio of 11.54 and a beta of 1.53. Piper Jaffray Companies has a 52 week low of $52.75 and a 52 week high of $99.80. The company has a quick ratio of 0.10, a current ratio of 1.54 and a debt-to-equity ratio of 0.17.
Hot Heal Care Stocks To Buy For 2019: Eagle Point Credit Company Inc.(ECC )
Advisors’ Opinion:
- [By Max Byerly]
Shares of EAGLE POINT Cr/COM (NYSE:ECC) have received an average recommendation of “Hold” from the six analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating and four have issued a buy rating on the company. The average 1-year target price among brokerages that have covered the stock in the last year is $21.13.
- [By Ethan Ryder]
Corporate Capital Trust (NYSE: CCT) and Eagle Point Credit (NYSE:ECC) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.
- [By Motley Fool Staff]
EAGLE POINT CREDIT COMPANY(NYSE:ECC) Q1 2018 Earnings Conference CallMay. 17, 2018 10:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Logan Wallace]
Eagle Point Credit Co (NYSE:ECC) insider Daniel M. Spinner purchased 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 22nd. The stock was acquired at an average cost of $73,933.00 per share, with a total value of $5,544,975,000.00. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
